| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Rahsan-Rahsan Lindsay CEO | OTC PINK Exchange | 58503D200 CUSIP |
| US Country | 69 Employees | - Last Dividend | 28 Nov 2007 Last Split | - IPO Date |
Medite Cancer Diagnostics, Inc. is a forward-thinking medical technology company based in Orlando, Florida. It is dedicated to advancing the field of cancer diagnostics through the development, manufacturing, and marketing of innovative molecular biomarkers, medical devices, and consumables. These products are focused on the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. With a global reach, Medite Cancer Diagnostics serves histology and cytology laboratories found in hospitals, research institutions, and independent labs across the United States, China, Europe, and North Africa. This broad market presence is supported through both direct sales and an extensive network of distributors.